BioCryst Pharmaceuticals | BCRX - Laba Operasional

Harga Saham
8.30
Perubahan Harian
-0.73 -8.08%
Bulanan
-13.45%
Tahunan
-17.66%
Q2 Perkiraan
9.00




Laba Operasional Perubahan Tanggal
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Chugai Pharma JPY 158.77B 10.24B 2026-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
DBV Technologies USD -34.28M 6.83M 2025-09
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Incyte USD 324.17M 59.7M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03